MedTrace Logo

InSeal VCD Large Bore Vascular Closure Device Safety and Effectiveness Clinical Study

NCT02628782 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2020-02-12

No results posted yet for this study

Summary

The InSeal vascular closure device (VCD) is assessed as percutaneous closure of artery access sites for quick hemostasis and ambulation in patients who have undergone large bore endovascular catheterization procedures.

The study hypothesis is that the VCD is safe and efficient in achieving hemostasis in the study population.

Conditions

  • Percutaneous Closure of Artery Access Sites

Interventions

DEVICE

InSeal's Vascular Closure Device

Intravascular closure device

Sponsors & Collaborators

  • InSeal Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Ran Kornowski, MD · Rabin Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-29
Primary Completion
2018-03-11
Completion
2019-01-22

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02628782 on ClinicalTrials.gov